Walter Fries

TL;DR: The European Crohn's and Colitis Organisation and the European Society of Pathology jointly elaborated a consensus to establish standards for histopathology diagnosis in IBD based on the highest level of evidence available, but significant gaps remain in certain areas.

TL;DR: Patients older than 65 years treated with TNF inhibitors for IBD have a high rate of severe infections and mortality compared with younger patients or patients of the same age that did not receive these therapeutics.

TL;DR: Infliximab is not superior to placebo in preventing clinical recurrence after CD-related resection, however, infliximab does reduce endoscopic recurrence.

TL;DR: Fecal calprotectin and lactoferrin appear to be equally recommendable as inflammatory disease markers in patients with lower gastrointestinal symptoms and both tests are needed to accurately discriminate activity in inflammatory bowel disease patients.

TL;DR: MR and CT are equally accurate to assess disease activity and bowel damage in CD and MR may be superior to CT in detecting intestinal strictures and ileal wall enhancement and may represent an alternative technique toCT in assessing ileocolonic CD.